New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 4, 2012
12:20 EDTRGLSRegulus Therapeutics to present new data on miR-21 at Kidney Week
Regulus Therapeutics announced that new preclinical data targeting microRNA-21, miR-21, will be presented at 10:00 a.m. PDT on November 3 in a late-breaking poster session at the American Society of Nephrology's Kidney Week 2012, meeting in San Diego, CA, October 30óNovember 4.
News For RGLS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
08:59 EDTRGLSRegulus Therapeutics data positive, says Wedbush
Subscribe for More Information
November 16, 2014
14:44 EDTRGLSRegulus, Sanofi present new data enhancing the preclinical profile of RG-012
Subscribe for More Information
November 13, 2014
10:27 EDTRGLSHigh option volume stocks
Subscribe for More Information
07:54 EDTRGLSRegulus Therapeutics 2M share Block Trade priced at $18.25
Morgan Stanley acted as sole book running manager for the offering.
November 10, 2014
15:06 EDTRGLSRegulus Therapeutics' RG-101 mentioned positively at BMO Capital
10:54 EDTRGLSRegulus hepatitis C drug not winning over doctors, TheStreet reports
Subscribe for More Information
10:14 EDTRGLSHigh option volume stocks
High option volume stocks: UN PAGP PHH RGLS DF URA CERS DNDN LGF CALL
November 7, 2014
16:57 EDTRGLSRA Capital reports 9.8% passive stake in Regulus Therapeutics
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use